Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical betamethasone and oral melatonin for atopic dermatitis
IRCT20200825048515N23Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Feb 2021
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of betamethasone and melatonin in atopic dermatitis (AD), sponsored by Isfahan University of Medical Sciences. Started Feb 2021; status: completed.
02
Drugs
betamethasonemelatonin
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on IRCT20200825048515N23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20200825048515N23.